Can iron deficiency or low ferritin cause anxiety?

Can Low Iron/Ferritin Cause Anxiety?

Yes, iron deficiency and low ferritin can directly cause anxiety symptoms, even before anemia develops. Recent high-quality evidence demonstrates that genetically determined low iron status causally increases the risk of anxiety disorders, and iron supplementation in non-anemic individuals with iron deficiency significantly reduces anxiety symptoms.

Causal Evidence Linking Iron Deficiency to Anxiety

Mendelian randomization studies—which use genetic variants to establish causality—confirm that low serum iron, low ferritin, and low transferrin saturation directly increase the risk of anxiety disorders. 1 For every 1 standard deviation decrease in ferritin, the odds of developing an anxiety disorder increase by approximately 15% (OR 0.873, meaning lower ferritin = higher anxiety risk). 1 This genetic evidence eliminates confounding and establishes that the relationship is causal, not merely associational.

Clinical Evidence in Real-World Populations

Non-Anemic Iron Deficiency and Anxiety

• Iron deficiency without anemia is independently associated with more severe anxiety symptoms, worse concentration, lower wellbeing, and reduced quality of life in multiple populations. 2
• In kidney transplant recipients, iron deficiency (defined as transferrin saturation <20% and ferritin <100 μg/L) was associated with a 100% higher risk of major depressive symptoms and significantly more anxiety, independent of anemia status. 2
• Adolescent females with serum ferritin <15 ng/mL exhibited significantly more severe anxiety symptoms compared to those with normal ferritin, even when hemoglobin was normal. 3
• In multiracial adolescents, iron deficiency with anemia was associated with markedly worse anxiety severity (Cohen's d = 3.00), but iron deficiency without anemia also showed elevated anxiety symptoms. 4

Iron Supplementation Reduces Anxiety

• Meta-analysis of randomized controlled trials demonstrates that iron supplementation in non-anemic individuals with iron deficiency reduces anxiety symptoms with a moderate effect size (Cohen's d = 0.34). 5
• This improvement occurs specifically in individuals with documented iron deficiency; when non-iron-deficient participants were excluded from analysis, the anxiety-reducing effect disappeared, confirming that iron repletion—not placebo—drives the benefit. 5

Mechanism: Brain Iron Depletion Occurs Early

• Brain iron stores become depleted at ferritin concentrations higher than the traditional diagnostic threshold of <15 μg/L. 3
• Adolescents with ferritin <20 ng/mL showed inverse correlations between ferritin and basal ganglia volumes (caudate, putamen), suggesting that brain iron depletion disrupts neurotransmitter synthesis and dopaminergic pathways involved in mood regulation. 3
• Iron is essential for synthesis of serotonin, dopamine, and norepinephrine—neurotransmitters directly implicated in anxiety pathophysiology. 5

Diagnostic Thresholds for Symptomatic Iron Deficiency

Traditional ferritin cutoffs (<15 μg/L) underestimate the prevalence of functionally significant iron deficiency. 6

• Physiologically based thresholds—derived from the point at which hemoglobin and soluble transferrin receptor begin to decline—are approximately 25 μg/L for women and 22 μg/L for children. 6
• Using these evidence-based thresholds, the prevalence of iron deficiency is 80% higher than estimates based on WHO guidelines (<15 μg/L for women, <12 μg/L for children). 6
• Ferritin <30 ng/mL in the absence of inflammation indicates depleted iron stores and warrants treatment, even when hemoglobin is normal. 7

Who Should Be Screened for Iron Deficiency When Presenting with Anxiety?

High-Risk Groups Requiring Screening

• Menstruating women: 38% have iron deficiency without anemia; 13% have iron-deficiency anemia. 7
• Pregnant women: Up to 84% develop iron deficiency by the third trimester. 7
• Individuals with chronic inflammatory conditions: IBD (13–90%), chronic kidney disease (24–85%), heart failure (37–61%), cancer (18–82%). 7
• Vegetarians/vegans, regular blood donors, and those with heavy menstrual bleeding. 7

Diagnostic Testing

• Measure serum ferritin and calculate transferrin saturation (serum iron ÷ TIBC × 100). 7
• In the absence of inflammation (normal CRP/ESR), ferritin <30 ng/mL confirms iron deficiency. 7
• In the presence of inflammation, use ferritin <100 μg/L combined with transferrin saturation <20% to diagnose iron deficiency. 8

Treatment Recommendations

Oral Iron Supplementation

• Initiate ferrous sulfate 325 mg daily (65 mg elemental iron) or 60–65 mg every other day; alternate-day dosing improves absorption by 30–50% and reduces gastrointestinal side effects. 7
• Continue supplementation for 3 months after hemoglobin normalizes to achieve ferritin >100 ng/mL and prevent recurrence. 7
• Expected response: anxiety symptoms should begin improving within 4–8 weeks of achieving iron repletion. 5

Intravenous Iron Indications

• Switch to IV ferric carboxymaltose (15 mg/kg, max 1000 mg per dose) if: oral intolerance, malabsorption (celiac disease, IBD, post-bariatric surgery), ongoing blood loss, chronic inflammatory conditions (CKD, heart failure, cancer), or second/third trimester pregnancy. 7

Critical Pitfalls to Avoid

• Do not dismiss anxiety symptoms as purely psychological when ferritin is <30 ng/mL, even if hemoglobin is normal. Iron deficiency causes real neurobiological dysfunction. 3, 5
• Do not wait for anemia to develop before treating iron deficiency in symptomatic patients. Brain iron depletion and anxiety symptoms occur before hemoglobin drops. 3, 6
• Do not use ferritin alone in patients with chronic inflammation (elevated CRP/ESR). Ferritin is an acute-phase reactant; transferrin saturation <20% is required to confirm iron deficiency when ferritin is 30–100 μg/L. 8
• Do not overlook celiac disease (present in 3–5% of iron-deficiency cases) or H. pylori infection, both of which impair iron absorption and cause treatment failure. 7